ASH 2010 Conference Coverage

Breast cancer is more accurately diagnosed after PET/CT imaging in younger patients

A change in diagnosis resulted from PET/CT imaging of patients who were younger than 40 years with an initial diagnosis of stage I-III breast cancer, according to a retrospective analysis.

For patients with low-risk prostate cancer managed with active surveillance, obesity may increase risk of progression

Obesity is linked with increased risk of progression of low-risk prostate cancers in active surveillance.

Smoking increases risk of second primary lung cancer (SPLC)

Increased tobacco exposure is linked with a higher risk of developing second primary lung cancers (SPLCs).

Gigapixel camera provides resolution and whole-body imaging for taking a "skin cancer selfie"

A gigapixel camera that takes high-resolution snapshots of the entire body could prove to be a new tool for whole-body skin cancer screening.

Targeting a unique receptor promising for glioblastoma multiforme

Glioblastoma multiforme (GBM) is one of the most lethal primary brain tumors, but new therapeutic strategies are being investigated.

Screening for Lynch syndrome improves health outcomes at an acceptable cost

Screening families of patients with colorectal cancer for a genetic condition would reduce their risk of developing related cancers, new research has determined.

Stem cell abnormalities in esophagus may lead to Barrett's esophagus or esophageal cancer

The esophagus has its own pool of stem cells despite previous findings that suggest the opposite.

HPV infection found to increase risk of lung cancer

Researchers have found that there is a strong association between lung tissue with human papillomavirus (HPV) infection.

Overdetection of PSA recurrence after radical prostatectomy more likely in older patients

For some men, prostate cancer recurrence may be overdetected, especially in those aged over 70.

Outcomes in nonsquamous lung cancer comparable with docetaxel or pemetrexed

The first direct comparison of treating nonsquamous lung cancer with either pemetrexed or docetaxel in addition to cisplatin has shown that the two combinations achieve similar progression-free survival.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs